|
Volumn 10, Issue 12, 2013, Pages 1209-1210
|
DGIdb: Mining the druggable genome
a a a a a a a a a a a a a a a,b a a a a a more..
b
USA
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIDERMAL GROWTH FACTOR RECEPTOR 3;
EPIDERMAL GROWTH FACTOR RECEPTOR 4;
G PROTEIN COUPLED RECEPTOR;
MAMMALIAN TARGET OF RAPAMYCIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN SERINE THREONINE KINASE;
PROTEIN TYROSINE KINASE;
TRANSCRIPTION FACTOR;
ARTICLE;
BREAST CANCER;
COMPUTER INTERFACE;
DATA MINING;
DRUG METABOLISM;
EXOME;
FOOD AND DRUG ADMINISTRATION;
GENE AMPLIFICATION;
GENE INTERACTION;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC DATABASE;
GENETIC VARIABILITY;
GENOME ANALYSIS;
GENOTYPE;
HISTONE MODIFICATION;
HUMAN;
LUNG CANCER;
PERSONALIZED MEDICINE;
PHARMACOGENOMICS;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN TARGETING;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
COMPUTATIONAL BIOLOGY;
DATA MINING;
DATABASES, GENETIC;
DRUG DISCOVERY;
DRUG INTERACTIONS;
GENE EXPRESSION REGULATION;
GENETIC VARIATION;
GENOME;
GENOMICS;
HUMANS;
LUNG NEOPLASMS;
MUTATION;
SOFTWARE;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 84888862866
PISSN: 15487091
EISSN: 15487105
Source Type: Journal
DOI: 10.1038/nmeth.2689 Document Type: Article |
Times cited : (405)
|
References (37)
|